Related Experiment Videos
Pathophysiological mechanisms of vascular calcification in end-stage renal disease
1Renal Division, Barnes-Jewish Hospital, St. Louis, Missouri, USA. daviesmat@hotmail.com
Insights
Vascular calcification is a significant risk factor for cardiovascular mortality, especially in end-stage renal disease (ESRD). Research is essential to understand its active mechanisms and implications for patient treatment.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Vascular Biology
Background:
- Vascular calcification is a known risk factor for cardiovascular mortality.
- It is highly prevalent in end-stage renal disease (ESRD) and linked to increased mortality markers like left ventricular hypertrophy.
- ESRD-related vascular calcification involves medial layer mineral deposition, differing from atheromatous plaque calcification in non-ESRD populations.
Purpose of the Study:
- To highlight the distinct pattern of vascular calcification in ESRD.
- To emphasize the need for clarifying the pathophysiological mechanisms of vascular calcification.
- To underscore the clinical importance of understanding vascular calcification in ESRD for current and future therapies.
Main Methods:
- Review of current evidence on vascular calcification mechanisms.
- Comparison of calcification patterns in ESRD and non-ESRD populations.
- Analysis of contributing factors to vascular calcification in ESRD, including hyperparathyroidism and mineral homeostasis disorders.
Main Results:
- Vascular calcification in ESRD predominantly affects the tunica media, unlike atheromatous plaque calcification in other populations.
- Evidence suggests vascular calcification is an active cellular process, not passive mineral precipitation.
- Factors like secondary/tertiary hyperparathyroidism, calcium/phosphate imbalance, and specific treatments contribute to vascular calcification in ESRD.
Conclusions:
- The distinct pattern of vascular calcification in ESRD has significant clinical implications.
- Understanding vascular calcification as an active, osteoblastic process is crucial.
- Further research into vascular calcification is essential for advancing clinical nephrology and patient care.
Abstract:
Vascular calcification has been clearly defined as a risk factor for cardiovascular mortality in the general population and is highly prevalent in end-stage renal disease (ESRD), where it is associated with a number of markers of increased mortality such as left ventricular hypertrophy. The pattern of calcification in ESRD is characterized by mineral deposition in the tunica media, in contrast to non-ESRD populations, where calcification of atheromatous plaque predominates. This difference may have important clinical implications. The pathophysiological mechanisms underlying both types of vascular calcification remain to be clarified; however, current evidence suggests that they are active processes rather than passive mineral precipitation, and the presence in the vasculature of cells expressing an osteoblastic phenotype may be of central importance. In ESRD, the presence of secondary and tertiary hyperparathyroidism, disordered calcium and phosphate homeostasis, and the use of vitamin D- and calcium-based treatments in its therapy may all contribute to vascular calcification. These issues and the impact on other current and future therapies have great importance for clinical nephrology, and a better understanding of vascular calcification through a focused research effort is essential.